Description

難易度:***
1>Beta放射配體藥物:
Zevalin: 90Y-anti-CD20 ibritumomab tiuxetan
Bexxar: 131I-anti-CD20 tositumomab
Lutathera: 177Lu-anti-somatostatin receptor dodecanetetraacetic acid tyrosine-3-octreotate (DOTATATE)
Pluvicto: 177Lu-PSMA-617

2>Alpha 放射配體藥物:
Xofigo: RaCl2
RYZ101: 225Ac-anti-somatostatin receptor 2 (SSTR2) somatostatin analogue
Actinium A: 225Ac-anti-CD33 Lintuzumab
FPI-1434: 225Ac-anti-IGF-1R mAb

#放射線治療 #放射線藥物 #放射配體 ＃radioligand therapy #RLT #Zevalin #Bexxar #Lutathera #Pluvicto # Xofigo #釔90 #碘131 #鎦177 #鐳227 #錒225 #砹211 #鉛212 #釷227 #RayzeBio #POINT Biopharma

請我喝杯咖啡吧https://open.firstory.me/join/science-up
小額贊助支持本節目： https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1
留言告訴我你對這一集的想法： https://open.firstory.me/user/ckn4fdez1q4vv0874tetbieq1/comments

Powered by Firstory Hosting